Generic Background Image

Clinical Trial/Research Study

Neuromodulation and Neurorehabilitation for Treatment of Functional Deficits after mTBI plus PTSD

IRB Protocol Number STU00203773

Contact

Katie Kestner ckestner@sralab.org

Objective

The purpose of this study is to alleviate persisting attention deficits related to mild TBI and PTSD by treating the neurocognitive system of attention.

Who Can Participate

  • Mild TBI/concussive event 3 months to 10 years ago
  • Have co-occuring mild TBI and PTSD

Compensation

Provided

Age Range

18-80

Apply for this Trial

Your information will not be published.

All fields are required.

More Studies

Developing a Daily Life Measure of Depression for People with Aphasia

The Shirley Ryan AbilityLab is conducting a research study to learn more about mood and depression in people with aphasia and develop an aphasia-accessible measure of depression.

read more

Mobile Outreach and Monitoring: Ecological Notification and Timely Support in SCI (MOMENT)

read more

Implantable System to Improve Blood Pressure Instability After Spinal Cord Injury

read more
view all

Latest Updates

woman

Word Finding: What’s Typical & When Should You Be Concerned?

Blog

AARP

AARP Features Shirley Ryan AbilityLab Research Advancing Stroke Rehabilitation

Blog

Dr. Monica Perez

From PT to PhD: Dr. Monica Perez Drives SCI Treatment Forward

News

view all